Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum–taxane therapy: A phase II Austrian AGO study

✍ Scribed by E. Petru; L. Angleitner-Boubenizek; A. Reinthaller; M. Deibl; A.G. Zeimet; B. Volgger; A. Stempfl; C. Marth

• Book ID: 113960421
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 90 KB
• Volume: 102
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2005.12.017